Market Place
Sourcing Support
GenScript’s ProBio Aids In Cancer Fight With Key Innovations
15 Nov 2024 //
PRESS RELEASE
ProBio Drives Chimagen’s Global Growth In Antibody Therapy
12 Nov 2024 //
PRESS RELEASE
ProBio, UCI Partner On Viral And Non-Viral Gene Delivery Tech
04 Sep 2024 //
PRESS RELEASE
GenScript ProBio Extends Congratulations to InnoBation Bio on MFDS Clearance
06 Feb 2024 //
PRESS RELEASE
GenScript, GenScript Pro, and Legend Biotech Will Attend the 42nd JPM Conference
04 Jan 2024 //
PR NEWSWIRE
GenScript Partners With NuclixBio to Pave the Way for Production Process
09 Nov 2023 //
BUSINESSWIRE
GenScript ProBio and Comprehensive Cell Solutions Form a Pioneering Partnership
07 Jun 2023 //
BUSINESSWIRE
GenScript ProBio Congratulates Eutilex’s IND Clearance from MFDS
07 Mar 2023 //
PRESS RELEASE
GenScript Expands Footprint in Singapore for Gene Synthesis Service
28 Feb 2023 //
CONTRACT PHARMA
GenScript ProBio, RVAC Medicines Enter GMP Plasmid DNA Manufacturing Pact
22 Feb 2023 //
CONTRACT PHARMA
Bio Immunitas Enters Manufacturing Collaboration with GenScript ProBio
09 Feb 2023 //
CONTRACT PHARMA
GenScript raises $224M for CDMO focused on antibodies, cell and gene therapies
18 Jan 2023 //
ENDPTS
Program CD47, provided the CMC service by GenScript to InnobationBio will further be advanced
05 Dec 2022 //
PRNEWSWIRE
GenScript ProBio Congratulates Selecxine on FDA Clearance of IND Application
23 Aug 2022 //
ASIAONE
GenScript Launches Expedited mRNA Service
18 Aug 2022 //
CONTRACTPHARMA
Two years after stepping down, Frank Zhang is back as Legend chair
05 Aug 2022 //
ENDPTS
GenScript ProBio signs MoU with ACT Tx to develop new CAR-T cell therapies
14 Jul 2022 //
BIOSPECTRUMASIA
GenScript ProBio and DAAN Bio Sign Strategic Cooperation MOU for Novel Drugs
13 Jul 2022 //
PRNEWSWIRE
AffyXell Expands its Strategic Partnership With GenScript ProBio
16 May 2022 //
BUSINESSWIRE
GenScript ProBio builds up presence in APAC
13 May 2022 //
BIOSPECTRUMASIA
GenScript strengthens manufacturing capability with new facility in Singapore
11 Feb 2022 //
BIOSPECTRUMASIA
Construction begins on GenScript`s new Singapore site; and more
10 Feb 2022 //
ENDPTS
GenScript ProBio Expanding Manufacturing Capacity Again
07 Dec 2021 //
PRNEWSWIRE
GenScript Opens Gene Synthesis Facility in New Jersey
02 Nov 2021 //
CONTRACTPHARMA
GenScript adopts automation at its new cell, gene therapy
02 Nov 2021 //
FIERCEPHARMA
GenScript inks pact with AskGene for sdAb targeting immune checkpoint target
28 Sep 2021 //
PHARMABIZ
GenScript signs manufacturing agreement with SYNIMMUNE for innovative Ab drug
06 Sep 2021 //
PRNEWSWIRE
Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing
14 Apr 2021 //
PRNASA
GenScript ProBio and Neoletix Announce Successful Completion of 200-Liter GMP
18 Feb 2021 //
PRNASIA
GenScript ProBio and Neoletix Announce Successful Completion of 200-Liter GMP
18 Feb 2021 //
PRNEWSWIRE
US FDA grants emergency use authorization to GenScript’s cPass SARS-CoV-2
12 Feb 2021 //
PHARMABIZ
GenScript Receives FDA Emergency Use Authorization for Use of cPass(TM)
11 Feb 2021 //
PRNEWSWIRE
GenScript receives FDA EUA to use cPass test in convalescent plasma screening
11 Feb 2021 //
BIOSPECTRUMASIA
